Mary Brenner, MSN MArch RN, is CRIO’s Study Design Manager and brings deep-rooted expertise as a registered nurse to CRIO’s in-house study design team. In this quick Q&A, Mary shares the benefits of good study design for sponsors and sites, the downstream effects of standardized study designs, and gives tips for designing it on your...
BOSTON, MA – August 9, 2022 – CRIO, a Boston-based healthcare technology company streamlining clinical trials for sponsors, sites and patients, announced that it has reached another milestone, exceeding 2,000 clinical research sites standardizing on CRIO’s eSource platform. CRIO supports a variety of clinical trial data. To date, over 800 life science sponsors have data...
CRIO is thrilled to announce the launch of the Study Design Marketplace, CRIO’s product hub for eSource study design templates. Tap in to Team CRIO’s vast experience and explore hundreds of pre-approved templates, curated just for you. Your time is precious. It’s up to you how you spend it. Accelerate the time it takes your...
CRIO, the leader in eSource technology, is announcing the launch of an industry first, CRIO Reviewer EDC, designed to create a fully integrated eSource/EDC system. Reviewer EDC allows sponsors and CROs to review, query, extract, code and lock data collected in the CRIO eSource application within minutes of site completion. This solution enables research sites...
Company Strengths Executive Management Team with Senior Industry Expert BOSTON, MA – April 19, 2022 – Clinical Research IO (CRIO), a Boston-based technology firm streamlining clinical trials for sponsors, sites, and patients, announced that Jonathan Andrus will join as President and Chief Operating Officer. Working collaboratively with the CRIO senior team, Andrus will focus on...
Reflections on the Summit The 2021 Global Site Solutions Summit, hosted by the Society for Clinical Research Sites, was an amazing event. The first in-person event that our company has attended in 18 months, the Summit provided an opportunity for CRIO to meet new people and reconnect with clients and friends alike. Post-Pandemic Trends, Here...
We know that clinical research changes are slow since it’s based on practices that require large, established data taxonomies. But at CRIO, we encourage pharma companies to adopt more gender-inclusive language. For example, some protocols may require only people assigned to one or the other sex at birth and if so, they should clearly state...
Remote consent is one of the main technological and operational advantages that support direct-to-patient recruitment. In Part 3 of our 7-part webinar, join the conversation around the willingness to adopt remote consenting services, as well as the challenges of multinational clinical trials covering different languages. Topics covered over the course of 7 sessions include: Part...
The staying power of technology after the pandemic The clinical trials industry has historically been slow to adopt innovation, but 2020 was a catalyst for transformation. Spurred on by the need for business continuity during the pandemic, sites and sponsors worldwide were highly motivated to reconsider business as usual, and many have adopted an array...
At the beginning of May 2020, many of the larger pharmaceutical companies released their first quarter financials and shared their plans to open up research amid the ongoing coronavirus crisis. Determined to return to near normal operations by the end of the year, sponsors said they would begin to lift enrollment holds and initiate new studies. According...
